Six new drugs have been approved for NHS use in Scotland, including treatments for advanced breast cancer, cervical cancer, lung cancer, a rare form of epilepsy, glaucoma, and HIV prevention. However, the Alzheimer’s drug Lecanemab was not approved due to cost concerns and uncertainty over its benefits, despite being licensed in Great Britain. Campaigners expressed disappointment but remain hopeful for future approvals.
1 Like